Brussels, 19/03/2012 (Agence Europe) - On Monday 19 March, eminent European scientists announced that a new clinical trial would begin on a European scale, aimed at treating volunteer stroke (or CVA - cardiovascular/cerebrovascular accident) victims with mild hypothermia. EuroHYP-1, the phase III clinical trial which is exceptionally widespread, will be subsidised by the European Commission under the seventh framework programme and deployed in 25 European countries. The trial will be...